Corrigendum to: Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib [Eur. J. Med. Chem. 172 (2019) 143-153].

Corrigendum to: Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib [Eur. J. Med. Chem. 172 (2019) 143-153]. Eur J Med Chem. 2020 Apr 03;195:112272 Authors: Poratti M, Marzaro G PMID: 32251743 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32251743?dopt=Abstract

Source: European Journal of Medicinal Chemistry - April 2, 2020 Category: Chemistry Authors: Poratti M, Marzaro G Tags: Eur J Med Chem Source Type: research

More News: Chemistry | Science